Conference Report: From challenges to solutions

Bioanalysis

Volumn 3, Issue 8, 2011, Pages 833-838

  Abbott, Richard W ^a   Gordon, Ben ^b   Van Amsterdam, Peter ^b   Lausecker, Berthold ^b   Brudny Kloeppel, Margarete ^b   Smeraglia, John ^c   Romero, Fernando ^d   Globig, Susanne ^e   Golob, Michaela ^b   Knutsson, Magnus ^f   Herling, Christian ^g   Vieser, Eva ^h   Timmerman, Philip ⁱ  

^a Shire Pharmaceuticals   (United Kingdom)

^b Servier ^*  (Switzerland)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^d Protein Sciences and Design   (United States)

^e Acetelion Pharmaceuticals Ltd   (Switzerland)

^f Ferring Pharmaceuticals AS   (Denmark)

^g NOVO NORDISK A S   (Denmark)

^h MICROMET AG   (Germany)

ⁱ JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DRUG;

ANALYTIC METHOD; BLOOD ANALYSIS; BLOOD COMPONENT; BLOOD SAMPLING; COMPUTER PROGRAM; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGENICITY; INTERMETHOD COMPARISON; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEDICAL SOCIETY; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PROCESS TECHNOLOGY; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BIOASSAY; CLINICAL CHEMISTRY; DRUG INDUSTRY; EUROPE; METHODOLOGY; NON PROFIT ORGANIZATION; STANDARD;

BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; CLINICAL CHEMISTRY TESTS; DRUG INDUSTRY; EUROPE; ORGANIZATIONS, NONPROFIT; PHARMACEUTICAL PREPARATIONS;

EID: 79955364477     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.52     Document Type: Conference Paper

References (0)